Treatment of Rheumatoid Arthritis with Certolizumab Pegol: Results from PROACTIVE, a Non-Interventional Study in the UK and Ireland

被引：0
|
作者：
Namita Kumar
Sophia Naz
Mark Quinn
John Ryan
Thomas Kumke
Tom Sheeran
机构：
[1] University Hospital of North Durham,
[2] North Manchester General Hospital,undefined
[3] York Hospital,undefined
[4] Cork University Hospital,undefined
[5] UCB Pharma,undefined
[6] Cannock Chase Hospital,undefined
来源：
Advances in Therapy | 2018年 / 35卷
关键词：
Anti-TNF; Arthritis; Certolizumab pegol; DAS28; DMARDs (biologic); Rheumatoid arthritis; Rheumatology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1426 / 1437
页数：11
相关论文
共 50 条
  • [1] Treatment of Rheumatoid Arthritis with Certolizumab Pegol: Results from PROACTIVE, a Non-Interventional Study in the UK and Ireland
    Kumar, Namita
    Naz, Sophia
    Quinn, Mark
    Ryan, John
    Kumke, Thomas
    Sheeran, Tom
    [J]. ADVANCES IN THERAPY, 2018, 35 (09) : 1426 - 1437
  • [2] ACHIEVEMENT OF TREATMENT RESPONSE WITH CERTOLIZUMAB PEGOL: RESULTS FROM AN INTERIM ANALYSIS OF PROACTIVE, A NON-INTERVENTIONAL STUDY IN REAL-LIFE RHEUMATOID ARTHRITIS PATIENTS IN THE UK AND IRELAND
    Kumar, Namita
    Kumke, Thomas
    Naz, Sophia
    Quinn, Mark
    Ryan, John
    Sheeran, Tom
    [J]. RHEUMATOLOGY, 2016, 55 : 99 - 99
  • [3] Certolizumab pegol for the treatment of rheumatoid arthritis
    Horton, Sarah
    Walsh, Ceara
    Emery, Paul
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (02) : 235 - 249
  • [4] The Effectiveness and Safety of Certolizumab Pegol in Rheumatoid Arthritis Patients in a Canadian Practice Setting: Two Year Results from the Non-Interventional F-alphasT CAN Study
    Bessette, Louis
    Haraoui, Boulos
    Chow, Andrew
    Fortin, Isabelle
    Dixit, Sanjay
    Khraishi, Majed
    Haaland, Derek
    Elmoufti, Sami
    Syrotuik, Jerry
    Shaikh, Saeed
    [J]. JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1050 - 1050
  • [5] Efficacy and Tolerability of Certolizumab pegol for the Treatment of rheumatoid Arthritis in clinical Practice in Germany: 3rd Interim Analysis of non-interventional Study "Fast"
    Burmester, G.
    Mueller-Ladner, U.
    Nuesslein, H.
    von Hinueber, U.
    Edelmann, E.
    Detert, J.
    Hoehle, M.
    Richter, C.
    Klopsch, T.
    Kumke, T.
    Fricke, D.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 100 - 100
  • [6] Leflunomide in the treatment of patients with early rheumatoid arthritis—results of a prospective non-interventional study
    Herbert Kellner
    Klaus Bornholdt
    Gert Hein
    [J]. Clinical Rheumatology, 2010, 29 : 913 - 920
  • [7] Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis
    Connock, M.
    Tubeuf, S.
    Malottki, K.
    Uthman, A.
    Round, J.
    Bayliss, S.
    Meads, C.
    Moore, D.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 1 - 10
  • [8] Open Label, Prospective, Non-Interventional, Observational Study for the Safety and Efficacy of Certolizumab Pegol in Patients with Rheumatoid Arthritis in Everyday Routine Practice in Greece
    Vassilopoulos, Dimitrios
    Drosos, Alexandros A.
    Katsifis, Gikas E.
    Sakkas, Lazaros
    Mitas, Georgios
    Chouchouli, Konstantina
    Kumke, Thomas
    Settas, Lucas
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S25 - S25
  • [9] IMPROVEMENTS IN PRODUCTIVITY AT PAID WORK AND WITHIN THE HOUSEHOLD, AND INCREASED PARTICIPATION IN DAILY ACTIVITIES OVER 52 WEEKS OF CERTOLIZUMAB PEGOL TREATMENT OF RHEUMATOID ARTHRITIS: RESULTS OF A BELGIAN OBSERVATIONAL NON-INTERVENTIONAL STUDY
    Westhovens, R.
    Ravelingien, I
    Van de Vyvere, K.
    Pansar, I
    Purcaru, O.
    Kumke, T.
    Gyselbrecht, L.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A545 - A546
  • [10] Cigarette smoking and clinical response to certolizumab pegol treatment in Hungarian, Czech, and Slovak patients with rheumatoid arthritis: 104-week data from the CIMDORA prospective, non-interventional study
    Szekanecz, Z.
    Koncz, A.
    Dunkel, J.
    Vencovsky, J.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (06) : 1010 - 1018
12345